Order Article Reprints

Sharo C, Zhang J, Zhai T, Bao J, Garcia-Epelboim A, Mamourian E, Shen L, Huang Z. Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer’s Disease. Targets. 2024; 2(4):446-469. https://doi.org/10.3390/targets2040025

Sharo, Catherine, Jiayu Zhang, Tianhua Zhai, Jingxuan Bao, Andrés Garcia-Epelboim, Elizabeth Mamourian, Li Shen, and Zuyi Huang. 2024. "Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer’s Disease" Targets 2, no. 4: 446-469. https://doi.org/10.3390/targets2040025

Sharo, C., Zhang, J., Zhai, T., Bao, J., Garcia-Epelboim, A., Mamourian, E., Shen, L., & Huang, Z. (2024). Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer’s Disease. Targets, 2(4), 446-469. https://doi.org/10.3390/targets2040025